ArticleJACC. Case reports2026
Takotsubo Cardiomyopathy and Cardiogenic Shock in a 16-Year-Old With Vaping-Induced Pneumonitis.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTakotsubo cardiomyopathy (TC) is an uncommon diagnosis, particularly in the pediatric population. The midventricular subtype and presentation with cardiogenic shock are even more unique; the recognition of TC is critical for appropriate management. CASE SUMMARY: We present the case of a 16-year-old young woman who presented with cardiogenic shock. Cardiac magnetic resonance (CMR) confirmed left ventricular dilation, reduced systolic function, and myocardial edema, which are highly consistent with a diagnosis of TC, likely as a consequence of e-cigarette or vaping product use-associated lung injury. The patient was managed with high-dose corticosteroids, beta-blocker, and angiotensin-converting enzyme inhibitor therapy, with recovery of left ventricular function. DISCUSSION: This case emphasizes the importance of recognition of TC in pediatric patients as a cause of cardiogenic shock. The use of CMR is crucial to differentiate causes of undifferentiated cardiogenic shock. TAKE-HOME MESSAGES: Our case highlights the role of CMR as a valuable tool in the diagnosis of acute myocardial dysfunction and potential causes of TC in the adolescent population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.